This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Apeiron Synthesis S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Andrzej Jan Tracz: Innovator in Cancer Treatment
Introduction
Andrzej Jan Tracz is an inventor based in Wilczyce, Poland. He is currently associated with Apeiron Synthesis S.A. Tracz has made significant contributions to the field of cancer treatment through his innovative research and patent applications.
Latest Patent Applications
Tracz has filed several notable patent applications, including:
1. **Targeted Protein Degradation Using Bifunctional Compounds That Bind Ubiquitin Ligase and Target MCL-1 Protein** - This application describes a compound of formula (I); [MCL-1 ligand moiety]-[linker]-[ligase ligand moiety] (I); or a salt, solvate, hydrate, isomer or prodrug thereof, wherein [MCL-1 ligand moiety] is a compound of Formula (A), Formula (B) or Formula (C), and its use in the treatment of cancer.
2. **Novel Ruthenium Complexes, Methods of Their Preparation and Application Thereof in Olefin Cross Metathesis** - This application relates to novel ruthenium complexes of general formula 4 in which the substituents are defined herein. The present disclosure also relates to methods for preparing such compounds and their use as catalysts and/or (pre)catalysts in olefin cross metathesis.
Conclusion
Andrzej Jan Tracz is a dedicated inventor whose work focuses on innovative solutions for cancer treatment. His latest patent applications reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile